Cargando…
Construction and validation of a two-gene signature based on SUMOylation regulatory genes in non-small cell lung cancer patients
BACKGROUND: Post-translational modification plays an important role in the occurrence and development of various tumors. However, few researches were focusing on the SUMOylation regulatory genes as tumor biomarkers to predict the survival for specific patients. Here, we constructed and validated a t...
Autores principales: | Sheng, Hongxu, Hao, Zhexue, Zhu, Linhai, Zeng, Yuan, He, Jianxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125860/ https://www.ncbi.nlm.nih.gov/pubmed/35606717 http://dx.doi.org/10.1186/s12885-022-09575-4 |
Ejemplares similares
-
A five-m6A regulatory gene signature is a prognostic biomarker in lung adenocarcinoma patients
por: Wu, Xiao, et al.
Publicado: (2021) -
Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021) -
SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Chen, Zhike, et al.
Publicado: (2023) -
A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genes
por: Wang, Jianping, et al.
Publicado: (2023) -
Construction and validation of an eight-gene signature with great prognostic value in bladder cancer
por: Yan, Xin, et al.
Publicado: (2020)